Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Link opens in a new tab
Search content at Hong Kong Baptist University
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Student theses
Datasets
View Scopus Profile
Kam Wa CHAN, Prof
Assistant Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0002-3175-1574
Email
chriskwc
hkbu.edu
hk
Accepting PhD Students
2011
2026
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(9)
Research Output
(55)
Prizes / Awards
(2)
Activities
(47)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Kam Wa CHAN is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Chinese Medicine
81%
Diabetic Kidney Disease
51%
Meta-analysis
47%
Systematic Meta-analysis
47%
Chronic Kidney Disease
47%
COVID-19
46%
Integrative Medicine
44%
Pragmatic Clinical Trial
31%
Diabetes
30%
Estimated Glomerular Filtration Rate
28%
Retrospective Cohort Study
28%
Traditional Medicine
28%
Albumin-to-creatinine Ratio
27%
Diabetic Nephropathy
24%
Randomized Controlled Trial
23%
Catenin
23%
Acute Kidney Injury
23%
Traditional Chinese Medicine
23%
China
23%
Adverse Events
22%
Renal Replacement Therapy
21%
Clinical Trials
20%
Renal Tubule
20%
Complementary Medicine
19%
Clinical Evidence
18%
Complementary and
18%
Type 2 Diabetes Mellitus (T2DM)
16%
Western Medicine
16%
Kidney Injury
16%
Chronic Kidney Disease Patients
16%
Chinese Herbal Medicine
16%
Confidence Interval
16%
Hazard Ratio
15%
All-cause Mortality
15%
Aliskiren
15%
Direct Renin Inhibition
15%
Tubulointerstitial Fibrosis
15%
Hospital Registry
15%
Clinical Trial Design
15%
Parkinson's Disease
15%
IgA Nephropathy (IgAN)
15%
Immunogenicity
15%
Astragalus
15%
Rehmannia
15%
COVID-19 Vaccine
15%
Therapeutic Guidelines
15%
Therapeutic Evidence
15%
Epidemiological Evidence
15%
Evidence-based
15%
Kidney Transplant Recipients
15%
Medicine and Dentistry
Traditional Chinese Medicine
100%
Chronic Kidney Disease
53%
Medicine
48%
Systematic Review
47%
Integrative Medicine
44%
Randomized Controlled Trial
43%
COVID-19
39%
Diabetes
37%
Clinical Trial
33%
Meta-Analysis
33%
Glomerular Filtration Rate
27%
Retrospective Cohort Study
27%
Kidney Function
25%
Diabetic Nephropathy
24%
Acute Kidney Injury
23%
Adverse Event
22%
Creatinine
21%
Traditional Medicine
20%
Complementary Medicine
18%
Albumin
17%
Fibrosis
17%
Maturity Onset Diabetes of the Young
16%
Nephropathy
16%
Kidney Injury
16%
Chinese Herbal Medicine
16%
Parkinson's Disease
15%
Catenin
15%
Astragalus
15%
Hazard Ratio
15%
Kidney Fibrosis
13%
Diabetes Mellitus
12%
Patient with Type 2 Diabetes
12%
Downregulation
12%
Clinician
11%
Cardiovascular System
10%
Acute Renal Failure
10%
Clinical Trial Design
9%
Adjuvant Therapy
9%
Cardiovascular Disease
9%
Post-Hoc Analysis
9%
Homeopathy
8%
Lipid Metabolism
8%
Subgroup Analysis
8%
Side Effect
8%
Placebo
8%
Nuclear RNA
7%
Nucleotide Binding Oligomerization Domain Like Receptor
7%
Vorapaxar
7%
Cell Death
7%
Complement Component C5a
7%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
65%
Traditional Chinese Medicine
46%
Diabetic Nephropathy
39%
Randomized Controlled Trial
37%
Creatinine
30%
Adverse Event
27%
Cohort Study
25%
Clinical Trial
22%
Diseases
21%
Replacement Therapy
21%
Inflammation
21%
Albumin
20%
Fibrosis
18%
Maturity Onset Diabetes of the Young
17%
Aliskiren
15%
Renin Inhibitor
15%
Acute Kidney Failure
15%
Parkinson's Disease
15%
Astragalus
15%
Coronavirinae
15%
Immunoglobulin A Nephropathy
15%
Immunogenicity
15%
COVID-19 Vaccine
15%
All Cause Mortality
15%
Kidney Fibrosis
13%
Diabetes Mellitus
10%
Network Pharmacology
10%
Clinical Study
10%
Prevalence
10%
Ureter Obstruction
9%
Cardiovascular Disease
9%
Placebo
8%
Proteinase Activated Receptor 1
7%
Vorapaxar
7%
Atrasentan
7%
Endothelin Receptor Antagonist
7%
Complement Component C5a
7%
Periodontitis
7%
Chronic Obstructive Lung Disease
7%
Multiinfarct Dementia
7%
Herbal Agent
7%
Cytidine Phosphate
7%
Acetic Acid Derivative
7%
Chemotherapy
7%
Rehmannia
7%
Proline
7%
Catenin
7%
Kidney Injury
7%
Tablet
7%
Breast Cancer
7%